US 12,409,347 · Application 18/762,296 · Granted Sep 9, 2025

US 12,409,347

Betacoronavirus mrna vaccines

Estimated expiration

October 21, 2036

10y 24d remaining

Confidence: high

Earliest effective filing

Oct 21, 2016

+ 20 years

Oct 21, 2036

PTA +0d

Oct 21, 2036

TD applied

Oct 21, 2036

Final

Oct 21, 2036

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date: July 2, 2024
Earliest effective filing: October 21, 2016
Issue date: September 9, 2025
PTA: 0 days
Base expiry (before PTA): October 21, 2036

October 21, 2016 + 20 years = October 21, 2036

Continuation of application 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of application 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of application 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of application 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of application 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of application PCTUS2016058327, filed Oct 21, 2016
Continuation of application PCTUS2016058327, filed Oct 21, 2016
Continuation of application 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of application PCTUS2016058327, filed Oct 21, 2016
Continuation of application 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of application 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of application PCTUS2016058327, filed Oct 21, 2016
Continuation of application 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of application 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of application 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of application PCTUS2016058327, filed Oct 21, 2016
Continuation of application 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of application 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of application 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of application 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of application PCTUS2016058327, filed Oct 21, 2016
PRO62/245,031 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/244,813 — Provisional — not used for base term
PRO62/245,031 — Provisional — not used for base term
PRO62/244,837 — Provisional — not used for base term
PRO62/244,946 — Provisional — not used for base term
PRO62/244,802 — Provisional — not used for base term
PRO62/247,483 — Provisional — not used for base term
PRO62/247,297 — Provisional — not used for base term
PRO62/247,362 — Provisional — not used for base term
PRO62/247,394 — Provisional — not used for base term

Terminal disclaimers

TD approved2 approved, 2 filed

TD caps expiration to October 21, 2036

US 12,409,347· Application 18/762,296(from application 18/762,296)Capping patent
Betacoronavirus mrna vaccines
Filing date
Jul 2, 2024
Earliest effective filing
Oct 21, 2016
Issue date
Sep 9, 2025
PTA
0 days
Calculated expiration
Oct 21, 2036
Continuation of 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Oct 21, 2016 + 20y = Oct 21, 2036
US 12,551,734· Application 19/000,377(from application 19/000,377)
Betacoronavirus mrna vaccines
Filing date
Dec 23, 2024
Earliest effective filing
Oct 21, 2016
Issue date
Feb 17, 2026
PTA
0 days
Calculated expiration
Oct 21, 2036
Continuation of 18/762,372, filed Jul 2, 2024, issued as US 12,208,288
Continuation of 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of 18/762,296, filed Jul 2, 2024, issued as US 12,409,347
Continuation of 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 18/762,384, filed Jul 2, 2024, issued as US 12,521,577
Continuation of 18/528,323, filed Dec 4, 2023, issued as US 12,403,335
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Oct 21, 2016 + 20y = Oct 21, 2036
US 10,702,600· Application 16/805,587
Betacoronavirus mrna vaccine
Filing date
Feb 28, 2020
Earliest effective filing
Oct 21, 2016
Issue date
Jul 7, 2020
PTA
0 days
Calculated expiration
Oct 21, 2036
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Oct 21, 2016 + 20y = Oct 21, 2036
US 10,933,127· Application 16/880,829
Betacoronavirus mrna vaccine
Filing date
May 21, 2020
Earliest effective filing
Oct 21, 2016
Issue date
Mar 2, 2021
PTA
0 days
Calculated expiration
Oct 21, 2036
Divisional of 16/805,587, filed Feb 28, 2020, issued as US 10,702,600
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Oct 21, 2016 + 20y = Oct 21, 2036
US 12,403,335· Application 18/528,323(from application 18/528,323)
Betacoronavirus mrna vaccines
Filing date
Dec 4, 2023
Earliest effective filing
Oct 21, 2016
Issue date
Sep 2, 2025
PTA
0 days
Calculated expiration
Oct 21, 2036
Continuation of 16/897,734, filed Jun 10, 2020, issued as US 11,872,278
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Continuation of 16/368,270, filed Mar 28, 2019, issued as US 10,702,599
Continuation of 16/040,981, filed Jul 20, 2018, issued as US 10,272,150
Continuation of 15/674,599, filed Aug 11, 2017, issued as US 10,064,934
Continuation of PCTUS2016058327, filed Oct 21, 2016
Oct 21, 2016 + 20y = Oct 21, 2036

Notes (1)

[TD_REFS_TRUNCATED] Found 7 TD references; resolving first 5 only

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

The prosecution record for your AI

Application 18/762,296 · US 12,409,347

You have the date. Your AI can have the file.

PatentReply compiles the prosecution history behind US 12,409,347: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new public application a month is free. The first compile takes a few minutes.

Connect PatentReply See the evidence

Strategy and filing changes require your approval.

Look up another patentWho owns this patent?

Permanent link

www.patentreply.ai/tools/patent-expiration/US12409347

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.

Estimated expiration

Calculation details

Base term

Continuity chain(84 links)

Terminal disclaimers

Referenced patents(5)

Notes (1)

You have the date. Your AI can have the file.